Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2026-02-02 @ 6:56 PM
Study NCT ID:
NCT03211195
Status:
COMPLETED
Last Update Posted:
2022-04-25
First Post:
2017-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sotagliflozin Bioequivalence Study
Sponsor:
Sanofi
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Type 2 Diabetes Mellitus | View |
Keywords: